Is a complete INMB research report available?

No complete published report is available for INmune Bio Inc. (INMB) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

INmune Bio Inc. (INMB)

NASDAQ: INMB · USD

$1.77

+0.08 (+4.7%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first INMB analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	47.1M
Net income (ttm)	-41.6M
EPS (ttm)	-$1.61
Shares out	26.6M
Volume	134,174
Beta	0.98
Price target	$7.00	+295.5%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -41.6M
EPS (ttm): -$1.61
Market cap: 47.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All INMB indicators

Market & fundamental data

Available fields

184

Groups with data

Currency

USD

Showing 184 of 184 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001711754
Company name	INmune Bio Inc.
Country	United States
Country code	US
Cusip	45782T105
Employees	21
Employees Change	-1%
Employees Change Percent	-4.55
Enterprise value	$26.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2019-02-04
Isin	US45782T1051
Last refreshed	2026-07-31
Market cap	$47.1M
Market cap category	Nano-Cap
Price	$1.77
Price currency	USD
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	2836
Symbol	INMB
Website	https://www.inmunebio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-88.91%
FCF yield	-43.18%
P/B ratio	2.29x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-41.6M
Net Income Growth Quarters	3%
Net Income Growth Years	0%
Profit Per Employee	$-2M
ROA	-52.61
Roa5y	-35.88
ROCE	-211.9
ROE	-168.8
Roe5y	-87.2
ROIC	-65.43

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-44.01%
Cagr3y	-40.56%
Cagr5y	-35.48%
EPS Growth Quarters	3
EPS Growth Years	1
Revenue Growth	257.14x
Revenue Growth Years	1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$25.8M
Cash	$21.4M
Current Assets	$22.8M
Current Liabilities	$5.4M
Debt	$1.5M
Debt Equity	$0.08
Equity	$19.6M
Liabilities	$6.2M
Long Term Assets	$3M
Long Term Liabilities	$806,000
Net Cash	$19.8M
Net Cash By Market Cap	$42.42
Net Cash Growth	4.52%
Net Debt Equity	$-1.01
Tangible Book Value	$19.6M
Tangible Book Value Per Share	$0.74
WACC	9.32

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.24
Net Working Capital	$-3.2M
Quick ratio	4.11
Working Capital	$17.4M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-22.4%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-43.99%
200-day SMA	1.54
3Y total return	-79%
50-day SMA	1.56
50-day SMA vs 200-day SMA	50over200
5Y total return	-88.81%
All Time High	30.37
All Time High Change	-94.17%
All Time High Date	2021-09-07
All Time Low	1.09
All Time Low Change	62.39%
All Time Low Date	2026-03-31
ATR	0.15
Beta	0.98
Beta1y	2.36
Beta2y	1.1
Ch YTD	13.46
High	1.78
High52	3
High52 Date	2025-07-30
High52ch	-41%
Low	1.69
Low52	1.09
Low52 Date	2026-03-31
Low52ch	62.39%
Ma50ch	13.24%
Premarket Change Percent	1.78
Premarket Price	$1.72
Premarket Volume	508
Price vs 200-day SMA	14.64%
RSI	52.42
RSI Monthly	37.5
RSI Weekly	52.76
Sharpe ratio	-0.45x
Sortino ratio	-0.58
Total Return	-22.4%
Tr YTD	13.46
Tr1m	9.26%
Tr1w	2.91%
Tr3m	33.08%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Count Top	0
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.2
Operating Income	$-26.8M
Price target	$7
Price Target Change	$295

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	22,131,574%
Float Percent	83.25%
Shares Insiders	11.28%
Shares Institutions	20.43%
Shares Out	26,585,258
Shares Qo Q	-0.08%
Shares Yo Y	22.4%
Short Float	10.77%
Short Ratio	1.63
Short Shares	8.97

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-29.5M
Adjusted OCF	-28,492,000
Average Volume	692,544.1x
Bv Per Share	0.74
CAPEX	$-1M
Ch1m	9.26
Ch1w	2.91
Ch1y	-43.99
Ch3m	33.08
Ch3y	-79
Ch5y	-88.81
Ch6m	13.46
Change	4.73%
Change From Open	4.12
Close	1.69
Days Gap	0.59
Depreciation Amortization	136,000
Dollar Volume	237,488
Earnings Date	2026-08-06
Earnings Time	amc
EBIT	$-43.3M
EBITDA	$-43.3M
EPS	$-1.61
F Score	2
FCF	$-20.2M
FCF EV Yield	-74.99x
FCF Per Share	$-0.76
Financing CF	22,338,000
Fiscal Year End	December
Founded	2,015
Investing CF	-1,042,000
Ipr	-78
Iprfo	-79.15
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-30
Ma150	1.47
Ma150ch	20.16%
Ma20	1.83
Ma20ch	-3.07%
Net CF	2,021,000
Next Earnings Date	2026-08-10
Open	1.7
Optionable	Yes
Position In Range	88.89
Ppne	2,313,000
Pre Close	1.69
Price Date	2026-07-30
Ptbv Ratio	2.38
Relative Volume	0.19x
Share Based Comp	9,331,000
Tr6m	13.46%
Us State	Florida
Volume	134,174
Z Score	-6.61

INmune Bio Inc. (INMB)

Coverage state: Market snapshot only — no published research

Generate the first INMB analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · INMB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All INMB indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on INMB

Frequently asked questions